yy777 online casino
28th World Investment Conference Kicks Off in Riyadh, Uniting Global Leaders in Investment for Sustainable GrowthIrrigation, Food, and Civil Supplies Minister N. Uttam Kumar Reddy reaffirmed Telangana government’s vision to position Hyderabad as a global hub for Artificial Intelligence (AI). Speaking at the curtain-raiser for the 1st ISF Global AI Summit and International Junicorns Startup Festival, at the International Institute of Information Technology Hyderabad (IIIT-H) on Monday, he underscored the State’s efforts to harness AI for inclusive growth and innovation. Highlighting both opportunities and challenges presented by AI, Mr. Reddy highlighted its potential to transform industries and drive growth while addressing concerns such as job disruption and ethical dilemmas. He detailed the Telangana government’s initiatives, including the ambitious AI City project and the establishment of a Skills University, aimed at developing a skilled workforce and fostering collaboration with industry and academia to navigate the ethical complexities of AI. Describing AI as a transformative force across sectors like healthcare, education, smart mobility and manufacturing, Mr. Reddy called for collective effort to address future challenges, particularly the demands for computational power and the importance of AI ethics. He urged governments, industries, and academic institutions to work together to create ethical frameworks and develop AI systems that serve humanity. The International Startup Foundation formally announced the 1st Global AI Summit and International Junicorns Startup Festival, scheduled to take place in Dallas, USA, from May 28 to 30, 2025. Published - December 17, 2024 12:41 am IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit
Dallas Cowboys star guard Zack Martin is doubtful for Sunday's game against the Washington Commanders due to ankle and shoulder injuries. Martin didn't practice at all this week. He also physically struggled during Monday night's loss to the Houston Texas. Martin, who turned 34 on Wednesday, has started all 162 games played in 11 seasons with the Cowboys. He's a nine-time Pro Bowl selection and a seven-time first-team All-Pro. Tight end Jake Ferguson (concussion) and safety Markquese Bell (shoulder) have been ruled out. Neither player practiced this week after being hurt against the Texans. Cornerback DaRon Bland (foot) practiced in full this week and will make his season debut. He was injured in August. Star wideout CeeDee Lamb (back/foot) was a full practice participant on Friday and is good to go. Cornerback Trevon Diggs (groin/knee) and receiver Brandin Cooks (knee) are among six players listed as questionable. The others are offensive tackle Chuma Edoga (toe), guard Tyler Smith (ankle/knee), defensive end Marshawn Kneeland (knee) and linebacker Nick Vigil (foot). --Field Level MediaNone
NASHVILLE — The Supreme Court on Wednesday will consider for the first time whether states can ban certain gender transition medical treatments for young people – a closely watched case brought by three transgender teens, their parents and a doctor, all seeking to ensure health care access they say is critical. At issue is a Tennessee law barring transgender minors from using puberty blockers and hormones, treatments the state characterizes as risky and unproven. Lawmakers said the state should instead encourage adolescents to “appreciate their sex, particularly as they undergo puberty.” The court’s ruling might have implications for the more than 100,000 transgender adolescents living in Tennessee or one of the 23 other states that has banned using the drugs to treat minors with gender dysphoria. The question of whether and how to medically treat young people whose gender identity is different than their sex assigned at birth has become a polarizing issue, one President-elect Donald Trump seized on in advertisements targeting transgender people during his campaign. The Supreme Court in 2020 extended employment protections to lesbian, gay, bisexual and transgender workers, but it has yet to rule on the constitutionality of lower court decisions involving bathroom access, athletes and medical treatment for transgender minors like 16-year-old L.W., one of the Tennessee teens behind the case at the high court. Her parents, Brian and Samantha Williams, now drive her five hours to receive care in North Carolina. The teen started gender care treatments when she was 12 and said they have allowed her to “get to be myself a little bit more.” “It took a huge stressor off my back,” L.W. said in an interview. “I have more friends now because I’m more confident, and I’m more able to socialize.” The Biden administration and the American Civil Liberties Union are representing the parents and teens, who are referred to in court filings by their initials or a pseudonym to protect their identity. The families say the Tennessee law amounts to unconstitutional sex discrimination and a broad restriction on treatments that nearly every major medical association says are appropriate and effective for minors. ACLU attorney Chase Strangio, who is arguing on behalf of the families, will be the first openly transgender lawyer to present a case before the Supreme Court. Tennessee’s Republican attorney general Jonathan Skrmetti says in court filings that states have long had the power to regulate medicine and that there is nothing unconstitutional about restricting the use of a drug for certain purposes, even when it can be used for treating other conditions, or imposing age limits for health treatments when the risks and rewards are too uncertain. One potential wild card in the resolution of the case is the incoming Trump administration and the possibility that the next solicitor general will flip the federal government’s position to align with Tennessee’s view. If that were to happen, the court could allow the ACLU to continue challenging the law on its own, which would keep the justices on track to issue a ruling by the end of June. Trump transition officials did not immediately respond to questions about the case before the court, but his team has said Trump intends to fulfill his campaign promises, which included a crackdown on gender transition care for minors. PATIENTS AND LAWMAKERS CLASH L.W. said she began to suspect she was trans in 2019, when she was 11. She’d long felt as if she were “drowning,” but she didn’t understand why. She wore baggy clothes to obscure her body, and she panicked the first time she saw a few facial hairs above her lip. She was so uncomfortable in boys bathrooms, she avoided ever using one at school. Eventually, she developed urinary tract infections. After a cousin came out as trans, L.W. began researching on YouTube and Google. But she was scared, so she didn’t tell her parents she thought she was trans until just after Thanksgiving in 2020, more than a year after she’d first put a name to her feelings. Brian and Samantha Williams both had gay friends, and they told L.W. they supported her, but neither felt comfortable immediately taking her to a doctor. L.W. was 12, and Brian worried the distress she felt might be normal puberty angst. “It’s not like we took this thing lightly and just did it,” Brian said. The family went to a progressive church, and the church had a therapist on staff who specialized in trans youth, so Samantha and Brian signed L.W. up for counseling. After roughly six months, the therapist diagnosed L.W. with gender dysphoria and recommended a team of doctors at Vanderbilt Children’s Hospital. At Vanderbilt, L.W. underwent tests, then, in the summer of 2021, her doctors prescribed the drug Lupron to stop her body from going through male puberty. The medication, which has been used for at least 30 years on patients who start puberty too early, is largely reversible, but it can affect a young person’s bone density if taken long term without hormone therapy. The teen said she felt instantly relieved. To her, the benefits “strongly outweighed” any side effects. At the time, no state had banned trans adolescents from receiving the kind of care Vanderbilt’s team offered. Doctors nationwide had been treating a few thousand young people a year with hormones and puberty blockers, according to data compiled for Reuters – a tiny fraction of America’s adolescent population. They faced little pushback. Multiple peer-reviewed studies have found that a majority of trans adolescents experience “satisfaction,” “confidence” and “improvements in psychosocial functioning” after such treatment. Almost as soon as L.W. left her first appointment, she asked to start estrogen, but her doctors and her parents decided to wait. L.W. went in for regular evaluations, and in September 2022, more than a year after she started Lupron, her doctors agreed to prescribe estrogen. Hormone therapy made life feel possible in ways it never had before, L.W. said. She started hugging her family. She recorded music and built Lego models. She and her younger brother staged Airsoft matches with other teenagers. Neighbors even told Samantha that L.W. talked to them for the first time. L.W.’s journey felt personal to her, a singular distress followed by her own unique wins. But her time at Vanderbilt coincided with a historic rise in gender dysphoria diagnoses. In 2021, about 42,000 young people nationwide received a diagnosis of gender dysphoria, nearly triple the number in 2017, according to data the technology company Komodo Health Inc. compiled for Reuters. The vast majority were not prescribed hormones or puberty blockers, the data shows. Still, as the numbers rose, lawmakers and activists across the country began to raise questions about gender clinics and the treatments doctors were offering. The same month L.W. started estrogen, the conservative podcast host Matt Walsh accused Vanderbilt of castrating, sterilizing and mutilating children for profit. Tennessee Gov. Bill Lee (R) promised to investigate the hospital. That fall, Walsh and a group of Republican state legislators held a “Rally to End Child Mutilation” in downtown Nashville. Only Arkansas and Alabama had passed bans on transition-related care at that point. But lawmakers in other conservative states signaled that they intended to prioritize similar restrictions. In March 2023, Tennessee adopted the legislation now before the Supreme Court. The law, known as SB 1, prohibits health-care providers from prescribing any puberty blocker or hormone for the purpose of enabling a minor to identify or live as “a purported identity inconsistent with the minor’s sex.” Providers who violate the law can be fined $25,000 for each prohibited treatment and are subject to disciplinary measures and potential civil liability in private lawsuits. Throughout the hearings on the legislation, Republican lawmakers treated gender dysphoria as if it were an illusion. A co-sponsor of the House bill described transitioning as a “fiction” and “fantasy.” Another representative said, “If you don’t know what you are, a boy or girl, male or female, just go in the bathroom and take your clothes off and look in the mirror and you’ll find out.” The Williams family watched the hearings, and Brian was infuriated. The lawmakers didn’t know his daughter. He and Samantha had taken L.W. to experts. They’d had what felt like a million hard conversations, and they’d followed the best evidence available. “All of a sudden to have a state come down and say that that’s not the right thing to do, that’s it’s abusive, that it’s wrongheaded, it’s just infuriating because I feel like I’m doing all the right stuff,” Brian said. EXPERIMENTATION OR DISCRIMINATION? After the bill became law, everyone in the Williams family agreed that discontinuing care wasn’t an option. L.W. was happy in ways she’d never been before she transitioned. If she stopped taking puberty blockers and estrogen, her body would begin to go through male puberty. She told her parents that was too painful to contemplate, let alone experience. Moving didn’t feel possible either. L.W.’s brother sobbed every time he thought about leaving his friends, and Brian’s elderly parents live in Nashville and rely on his help. That spring, Samantha saw an ACLU form that invited families to describe how they’d been affected by the legislation. She didn’t imagine, as she filled out the form, that she was signing up for a lawsuit that would eventually make its way to the Supreme Court. She only knew that she wanted to protect her daughter and she didn’t want to feel helpless anymore. Tennessee gave families four months to wean kids like L.W. off the medications, but in June, before the ban even took effect, Vanderbilt shut down its clinic. In June 2023, a District Court judge temporarily blocked the law, saying it discriminates based on sex and treats some teens differently because they are transgender. The judge said the benefits of the treatments are well-established and noted that Tennessee’s law bans the medications for a small subset of minors while making them available for adolescents who use them for other health issues. “If Tennessee wishes to regulate access to certain medical procedures,” wrote U.S. District Judge Eli Richardson, a Trump nominee, “it must do so in a manner that does not infringe on the rights conferred by the United States Constitution, which is of course supreme to all other laws of the land.” A divided panel of the U.S. Court of Appeals for the 6th Circuit soon reversed Richardson’s decision, rejecting the families’ claims of discrimination and allowing the state to enforce the law while litigation continues. Chief Judge Jeffrey Sutton said the law regulates gender transition treatments for all minors, regardless of sex, and concluded that Tennessee lawmakers could have rationally determined that the law was an appropriate response to perceived risks associated with the treatments. Sutton, a nominee of George W. Bush, also said courts should be wary of intervening in a highly contested political dispute. Judge Helene N. White, another Bush nominee, agreed with the majority that the Constitution envisions states acting as laboratories for democracies to resolve political debates, but dissented from the majority ruling. “When a fundamental right or freedom from discrimination is involved, experimentation has no place,” she wrote. At the Supreme Court, Solicitor General Elizabeth B. Prelogar is asking the justices to return the case to the 6th Circuit to apply a more stringent level of review, which she says should be triggered by a law that discriminates based on sex. The state, she wrote, ignores the benefits of gender-transition care and overstates the health risks. She also said the law’s stated goal of having teens “appreciate their sex” is based on stereotypical understandings of gender and cannot be used to justify the ban. Skrmetti, the Tennessee attorney general, said the state has the authority to protect minors from the risks of gender-transition treatment, and the federal government should not discount lawmakers’ concerns. He also objected to Prelogar’s characterization of the law as driven by stereotypes. It is not unconstitutional discrimination, Skrmetti argued, to say that drugs can be prescribed for one reason, but not another. L.W. will be in the courtroom on Wednesday, but she said she can’t comprehend the gravity of the case she’s a part of. Mostly, she has tried to continue to live the life gender care has made possible. The day the ACLU filed its petition, she went to high school, and she only told a few people in the Gender-Sexualities Alliance, or GSA, about the case. That night, she worried, briefly, that her name would be on a case that might be remembered along the same lines as Plessy v. Ferguson, the 1896 Supreme Court case that ruled it was constitutional for states to enact segregation laws. Eventually, L.W. decided it was out of her control, and plus, she had the drivers’ test for her learner’s permit to worry about, so she set aside her fears and let her lawyers handle the hard parts. She is a junior in high school now. She DJed a party this Halloween. She has broadened her social life, and she adopted a kitten the family named Mushroom. She wants to spend her free time traveling to look at colleges with aviation programs, but for now, she and her mother still make regular trips to get treatment in North Carolina. Traveling out of state for health-care she’d rather get at home is arduous. Until recently, her mother had to take unpaid time off work, and L.W. has to call in sick to the magnet high school where she takes three Advanced Placement classes. “I hate taking days off school, it’s, like, the worst thing ever,” she said. “I have very, very difficult classes. So I’ve got a lot to catch up on if I miss a single day.” The drive used to take five hours each way, but Hurricane Helene washed out one of the roads they take, and now, the journey will be much longer. Comments are not available on this story. Send questions/comments to the editors. « Previous Next »House and cars hit by gunfire in Pitt Meadows shooting SundayRegis Le Bris delivers verdict on Sunderland's draw with Bristol City( MENAFN - GetNews) "The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France)"Browse 146 market data Tables and 47 Figures spread through 208 Pages and in-depth TOC on "Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027 Legionella Testing Market is projected to grow from USD 296 million in 2022 to USD 439 million by 2027, at a CAGR of 8.2% from 2022 to 2027, according to a new report by MarketsandMarkets. The increasing need for rapid diagnostics, increasing incidence of disease, growing advancements in bacterial testing, and water testing regulations. However, a lack of reimbursement and difficulties in detection may affect market growth. Download PDF Brochure: The PCR segment accounted for the largest share of the legionella testing market, by test type segment, in 2021 The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR. The PCR holds the largest share of the market in 2021, mainly due to its simplicity and speed. Water testing segment to register the highest growth rate during the forecast period The legionella testing market has been segmented into water testing, IVD testing, and other applications. In 2021, the water testing segment accounted for the largest share of the market. Factors such as worldwide lifestyle changes and growing elderly population is driving the growth of the market. The water & other industries segment accounted for the largest share of the legionella testing, by end user segment, in 2021 Based on the end user, the market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end users. In 2021, the water & other industries segment accounted for the largest share of the legionella testing market. The growing population and urbanization, increasing water treatment regulations, and increased demand for new water resources is driving the growth of this segment. Request Sample Pages: North America is the largest regional market for legionella testing market The global market is segmented into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. The North American market growth can be attributed to the growing incidence of legionella-related diseases and growing elderly population. The major players operating in this legionella testing market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US). Get 10% Free Customization on this Report: MENAFN16122024003238003268ID1108999824 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Unlock Your Dream Job: Top 10 Data Science Job Profiles in 2025Marvell Earnings: What to Know and What the Stock Is Doing - Barron's
Macy’s Struggles and Its Bold New Chapter: Can the Iconic Retailer Make a Comeback?
Baylor exploring its depth while it deals with series of ailmentsTD Cowen Lowers Kohl’s (NYSE:KSS) Price Target to $16.00NoneAfter a thrilling double-overtime win over Fresno State, California Baptist makes the nearly 2,500-mile trip to Orlando to face Central Florida on Sunday. The Lancers (5-3) capped their time at the Acrisure Holiday Invitational in Palm Springs, Calif., with an 86-81 victory over the Bulldogs on Wednesday. That followed a last-second, 79-77 loss to SMU the day before. Dominique Daniels Jr. played 45 minutes against Fresno State and led California Baptist with 29 points. He paces the Lancers with 20.3 points per game, while Kendal Coleman averages 15.1 points and is shooting 59.7 percent form the floor. However, coach Rick Croy's team has struggled from 3-point range, shooting just 30.7 percent entering its first true road game this season. UCF (5-2) is coming off of an 84-76 win over Milwaukee last Wednesday despite being outrebounded 41-31. The Knights were helped by the heroics of senior guard Darius Johnson, who had 28 points as he shot a career-best 8-for-10 from beyond the arc. "Darius was terrific," UCF coach Johnny Dawkins said. "He's so comfortable in his leadership role now, he's leading our team and running the show, and our new players are becoming more comfortable playing with him. He's been a rock for us this season, and you love to see it out of a senior point guard." "I had an extraordinary night shooting the ball from three," Johnson said. "I rarely think that would happen again, but it's great. I know my teammates are going to have nights like that as well." Johnson is among the nation's leaders in minutes per game (36.6) and is shooting a team-high 50 percent from 3-point range (23 of 46). He, along with his fellow guard Jordan Ivy-Curry, are each averaging 16.9 points to lead UCF. The Knights opened the season with an impressive win over Texas A&M, now No. 20 in the AP poll, but lost both games at last weekend's Greenbrier Tip-Off, including a triple-overtime defeat against LSU on Sunday. UCF has not reached the NCAA Tournament since 2018-19. This will be the first meeting between the Knights and the Lancers, who will each have time off afterwards. UCF won't play until Dec. 8 against Tarleton State, while California Baptist is idle until its Dec. 11 game at San Diego State. --Field Level Media